NCT01155167

Brief Summary

The aim of the study is to facilitate radial artery access for cardiac catheterization. The investigators hypothesize that topical nitroglycerin and lidocaine will reduce radial artery spasm. Patients undergoing cardiac catheterization via the radial artery will be randomized to topical nitroglycerin + lidocaine versus placebo.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jul 2010

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 29, 2010

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 1, 2010

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2010

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2012

Completed
10 months until next milestone

Results Posted

Study results publicly available

May 15, 2013

Completed
Last Updated

September 25, 2018

Status Verified

May 1, 2013

Enrollment Period

1.1 years

First QC Date

June 29, 2010

Results QC Date

January 31, 2013

Last Update Submit

September 21, 2018

Conditions

Keywords

radial artery spasm

Outcome Measures

Primary Outcomes (1)

  • Change in Radial Artery Diameter

    The cross-sectional radial artery area was measured using a high frequency linear array transducer. All ultrasound measurements were made 2 cm proximal to the radial styloid process. Each measurement was performed 3 times and averaged. At least 30 minutes after the application of topical creams, the radial artery diameter was again measured in the same fashion.

    Baseline and after 30 minutes of drug application

Secondary Outcomes (2)

  • Radial Artery Spasm During Catheterization

    2 hours

  • Radial Artery Patency

    24 hours

Study Arms (2)

Placebo

PLACEBO COMPARATOR
Other: Placebo

Topical dilator

EXPERIMENTAL
Drug: Nitroglycerin and lidocaine

Interventions

Topical Nitroglycerin and lidocaine

Topical dilator
PlaceboOTHER

Placebo

Placebo

Eligibility Criteria

Age18 Years - 100 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing trans-radial cardiac catheterization

You may not qualify if:

  • inability to receive nitroglycerin or lidocaine due to allergy or medication interactions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California San Francisco Medical Center

San Francisco, California, 94143, United States

Location

Related Publications (1)

  • Beyer AT, Ng R, Singh A, Zimmet J, Shunk K, Yeghiazarians Y, Ports TA, Boyle AJ. Topical nitroglycerin and lidocaine to dilate the radial artery prior to transradial cardiac catheterization: a randomized, placebo-controlled, double-blind clinical trial: the PRE-DILATE Study. Int J Cardiol. 2013 Oct 3;168(3):2575-8. doi: 10.1016/j.ijcard.2013.03.048. Epub 2013 Apr 10.

MeSH Terms

Conditions

Spasm

Interventions

NitroglycerinLidocaine

Condition Hierarchy (Ancestors)

Neuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Nitro CompoundsOrganic ChemicalsAcetanilidesAnilidesAmidesAniline CompoundsAmines

Results Point of Contact

Title
Andrew Boyle MD
Organization
UCSF

Study Officials

  • Andrew Boyle, MBBS, PhD

    University of California, San Francisco

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 29, 2010

First Posted

July 1, 2010

Study Start

July 1, 2010

Primary Completion

August 1, 2011

Study Completion

August 1, 2012

Last Updated

September 25, 2018

Results First Posted

May 15, 2013

Record last verified: 2013-05

Locations